An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease

Last updated: February 27, 2025
Sponsor: AbbVie
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05916157
P23-529
  • Ages > 15
  • All Genders

Study Summary

Parkinson's disease (PD) is a neurological condition, which affects the brain. Some symptoms of PD are tremors, stiffness, and slowness of movement. The purpose of this study is to assess how safe and effective ABBV-951 is in treating participants with Parkinson's disease in real world setting.

ABBV-951 is an approved drug being developed for the treatment of PD in Japan. Approximately 250 adult participants over 15 years with a diagnosis of PD who are prescribed ABBV-951 by their physicians will be enrolled in this study across Japan.

Participants will receive ABBV-951 as prescribed their physician and followed for 52 weeks.

There is expected to be no additional burden for participants in this trial. Study visits may be conducted on-site or virtually as per standard of care.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with advanced Parkinson's disease (aPD).

  • Prescribed ABBV-951 as physicians' decision according to the approved label fortreatment of aPD.

  • Given informed consent (or by her/his legal representative, if it's a requirementfrom the participating hospital/clinic) for participating this study.

Exclusion

Exclusion Criteria:

  • Prior treatment with ABBV-951 for PD.

  • Currently participating in interventional clinical trials.

Study Design

Total Participants: 250
Study Start date:
November 30, 2023
Estimated Completion Date:
July 31, 2026

Connect with a study center

  • National Hospital Organization Asahikawa Medical Center /ID# 269115

    Asahikawa, Hokkaido 070-0901
    Japan

    Active - Recruiting

  • Ryugasaki Saiseikai Hospital /ID# 264435

    Ryugasaki, Ibaraki 305-0854
    Japan

    Active - Recruiting

  • University of Tsukuba Hospital /ID# 268353

    Tsukuba-shi, Ibaraki 305-8576
    Japan

    Active - Recruiting

  • Okatsu Hospital /ID# 262781

    Kagoshima-shi, Kagoshima 890-0067
    Japan

    Active - Recruiting

  • Kyoto Prefectural University of Medicine /ID# 267445

    Kyoto-shi, Kyoto 602-8566
    Japan

    Active - Recruiting

  • Sendai Nishitaga National Hospital /ID# 268349

    Sendai, Miyagi 982-8555
    Japan

    Active - Recruiting

  • Shiga Medical University Hospital /ID# 265637

    Otsu, Shiga 520-2192
    Japan

    Active - Recruiting

  • Shiga University of Medical Science Hospital /ID# 265637

    Otsu, Shiga 520-2192
    Japan

    Active - Recruiting

  • Dokkyo Medical University Hospital /ID# 269116

    Mibu, Tochigi 321-0293
    Japan

    Active - Recruiting

  • Juntendo University Hospital /ID# 264438

    Bunkyo-ku, Tokyo 113-8431
    Japan

    Active - Recruiting

  • Nitobe Memorial Nakano General Hospital /ID# 275668

    Nakano-ku, Tokyo 164-0011
    Japan

    Active - Recruiting

  • National Center of Neurology and Psychiatry - Kodaira /ID# 267372

    Xiaoping City, Tokyo 187-8551
    Japan

    Active - Recruiting

  • National Hospital Organization Utano Hospital /ID# 268350

    Kyoto, 616-8255
    Japan

    Active - Recruiting

  • University Hospital, Kyoto Prefectural University of Medicine /ID# 267445

    Kyoto, 602-8566
    Japan

    Active - Recruiting

  • Okayama Neurology Clinic /ID# 269117

    Okayama, 702-8005
    Japan

    Active - Recruiting

  • Juntendo University Hospital /ID# 264438

    Tokyo, 113-0033
    Japan

    Site Not Available

  • Municipal Toyonaka Hospital /ID# 271277

    Toyonaka, 560-0055
    Japan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.